Hsp70 and the Unfolded Protein Response as a Challenging Drug Target and an Inspiration for Probe Molecule

Leila Terrab1, Peter Wipf1

  • 1Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States.

Insights

Modulating Hsp70 ATPase activity impacts the unfolded protein response (UPR). This dual action can induce cancer cell death or promote neuronal survival, offering therapeutic potential for various diseases.

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Pharmacology

Background:

  • The unfolded protein response (UPR) is a critical cellular mechanism for maintaining protein homeostasis and cell survival under stress.
  • Hsp70 chaperone's ATPase activity plays a key role in regulating the UPR.
  • Dysregulation of protein homeostasis is implicated in various diseases, including cancer, neurodegeneration, and aging.

Purpose of the Study:

  • To explore the complex protein homeostasis network and its regulation by Hsp70.
  • To discuss strategies for modulating Hsp70 ATPase activity for therapeutic benefit.
  • To highlight the dual role of Hsp70 modulation in UPR-mediated cell fate.

Main Methods:

  • Review of existing literature on UPR and Hsp70.
  • Discussion of pharmacological approaches targeting Hsp70 ATPase activity.
  • Introduction of a chemical reaction development-inspired library of Hsp70 modulators.

Main Results:

  • Pharmacological modulation of Hsp70 ATPase activity can selectively trigger UPR-mediated cell death in cancer cells.
  • Alternatively, Hsp70 modulation can promote cell survival, preventing apoptosis in neuronal cells.
  • This dual effect suggests potential applications in treating malignancies, neurodegenerative diseases, and inflammatory conditions.

Conclusions:

  • Hsp70 modulation represents a promising therapeutic strategy with context-dependent outcomes.
  • Targeting Hsp70 offers a novel approach to managing diseases associated with protein misfolding and cellular stress.
  • Further research into Hsp70 modulators could lead to significant advancements in medicine.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.1K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
19.4K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.8K